Navigation Links
Alexza Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status
Date:3/17/2008

>

share $(2.13)

Shares used to compute basic

and diluted net loss per share 19,584

[1] Reflects operating results in accordance with U.S. generally accepted

accounting principles (or GAAP).

[2] Represents share-based compensation expense.

[3] Non-GAAP amounts exclude share-based compensation expense.

Alexza Pharmaceuticals, Inc.

(a development stage company)

Condensed Consolidated Balance Sheets

(in thousands)

December 31, December 31,

Assets 2007 2006

[1] [1]

Cash, cash equivalents and marketable

securities 69,391 42,623

Investments held by Symphony Allegro,

Inc. 39,449 49,956

Other current assets 13,432 1,263

Total current assets 122,272 93,842

Property and equipment, net 26,156 11,136

Other non-current assets 697 788

Total assets 149,125 105,766

Liabilities and stockholders' equity

Current liabilities 16,180 14,193

Non-current liabilities 33,002 7,056

Non-controlling interest in Symphony

Allegro, Inc. 23,952 34,743

Stockholders equity 75,991 49,774

Total liabilities and stockholders'

equity (deficit) 149,125
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Alexza Completes Target Enrollment in AZ-104 Phase 2a Clinical Trial in Migraine Patients
2. Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status
3. Alexzas AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache
4. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
5. Spherix Reports Second Quarter Earnings
6. Tapestry Reports Second Quarter 2007 Results
7. Callisto Reports on Second-Quarter 2007 Milestones
8. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
9. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
10. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
11. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... and TARRYTOWN, N.Y. , May 21, ... and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that ... online the positive Phase 2a study results of dupilumab ... an investigational monoclonal antibody targeting the alpha subunit of ... of both IL-4 and IL-13, drivers of Th2 (Type ...
(Date:5/21/2013)... Calif. , May 21, 2013 Abaxis, ... blood analysis systems, announced today that Martin ... at the Stifel Annual Dental & Veterinary Conference on ... conference will be held at Le Parker Meridien Hotel ... About Abaxis Abaxis develops, manufactures, markets ...
(Date:5/21/2013)... 2013 Reportlinker.com announces that a ... its catalogue:   ... Medical Devices in the US Market ... Changing Regulatory and Reimbursement Scenario for ...   Summary ...
Breaking Medicine Technology:Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 2Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 3Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 4Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 5Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 6Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 7Abaxis, Inc. to Present at the Stifel Annual Dental & Veterinary Conference 2Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market 2Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market 3Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market 4
... FARMINGTON, Conn., May 9, 2012 /PRNewswire-iReach/ -- ... new reports tracking the growth in the patient monitoring ... Devices, Players, Markets and Forecasts The convergence of ... initiatives is driving patient monitoring away from caregiver facilities ...
... Medical Outsourcing announced today that the company hired ... As a seasoned quality specialist with 18 years ... the quality systems for all of Millstone Medical,s ... with customers to ensure the highest quality standards. ...
Cached Medicine Technology:New Forecast Shows Patient Monitoring Systems Market to Reach $18.9 billion by 2016 2New Forecast Shows Patient Monitoring Systems Market to Reach $18.9 billion by 2016 3Millstone Medical Outsourcing Hires New Vice President Quality 2
(Date:5/21/2013)... Today, Zane Benefits, Inc. published a ... accounts. Zane Benefits, which provides comprehensive and flexible alternatives ... in defined contribution and http://HRA ... to Zane Benefits’ website, the Affordable Care Act (known ... in 2010 and impacts many areas of health care ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 Two executives ... Guidance (SBG) will identify which strategies can be most ... high-quality care to the members who are taking them, ... Services, Inc., “How to Manage Specialty Drugs to ... pharmaceuticals are now the main driver for rising prescription ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 While North ... synonymous with comprehensive travel guides. Brunswick Plantation & Golf ... packages that include access to 27 holes of "Top10" ... courses in North Carolina, knowing the Top 10 ... Lodges takes away the overwhelming task of selecting the ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 Octo ... technology and management consulting solutions to the Federal ... Business Development. In the newly created role, ... all aspects of the firm’s business development function ... proposal management functions, and leading strategies to achieve ...
(Date:5/21/2013)... HealthDay Reporter , , TUESDAY, May 21 (HealthDay News) ... therapy for patients having severe bouts of chronic obstructive ... days of glucocorticoid treatment with prednisone to treat COPD ... but with fewer chances for adverse side effects, they ... period of treatment was not less effective than 14 ...
Breaking Medicine News(10 mins):Health News:Zane Benefits Publishes New Information on HRA, HSA and FSA Accounts 2Health News:Zane Benefits Publishes New Information on HRA, HSA and FSA Accounts 3Health News:Consulting Firm Execs to Discuss Strategies for Effective Management of Specialty Drugs in AIS’s May 30 Webinar 2Health News:Brunswick Plantation & Golf Resort Named in Top 10 Golf Resorts in North Carolina 2Health News:Octo Consulting Group Appoints Tracy Denny as Vice President of Business Development 2Health News:COPD Patients May Do Fine With Shorter Course of Steroids 2Health News:COPD Patients May Do Fine With Shorter Course of Steroids 3
... ANN ARBOR, Mich. Some patients with large tumors on ... and radiation over surgery to remove the voice box. ... Center found that a single round of chemotherapy could identify ... "Organ preservation studies have excluded these patients because their tumors ...
... a lump is found in the breast of an adolescent ... breast cancer is rare in adolescents, and the vast majority ... that are related to hormones. A recent Loyola University ... Roentgenology suggests that a breast ultrasound examination might eliminate ...
... Texas, June 25 Leading business and health care ... the Texas Coalition for Worksite Wellness, "Call for Coverage ... provide employees with comprehensive smoking cessation benefits. The ... with comprehensive smoking cessation coverage by an additional 100,000 ...
... State and Federal Healthcare Policy and Regulatory Team , ... of the largest law firms in Florida and one ... today the expansion of its Healthcare practice with significant ... healthcare professionals have joined the practice in the firm,s ...
... is available in German . , ... requires time- and labor-intensive molecular-biological procedures. Established methods are ... burden is very low, for example during a phase ... types of micro-pumps without movable parts, scientists from the ...
... Health Plan One of 17 Platinum-Level Award winners , ... Plan have been honored by the National Business Group on ... innovative programs that promote a healthy workplace and for helping ... their own health and well-being. , , UPMC was ...
Cached Medicine News:Health News:U-M study finds voice box can be preserved, even with the largest cancers 2Health News:What should a teenage girl do if she finds a lump in her breast? 2Health News:Business, Health Care Leaders Call on Texas Employers to Cover Smoking Cessation Benefits for an Additional 100,000 People by 2010 2Health News:Business, Health Care Leaders Call on Texas Employers to Cover Smoking Cessation Benefits for an Additional 100,000 People by 2010 3Health News:Akerman Senterfitt Announces Expansion of Healthcare Practice 2Health News:Akerman Senterfitt Announces Expansion of Healthcare Practice 3Health News:Virus filters for medical diagnosis 2Health News:UPMC and UPMC Health Plan Recognized by National Business Group on Health As a Leading Employer Promoting Healthy Lifestyles for Its Employees 2Health News:UPMC and UPMC Health Plan Recognized by National Business Group on Health As a Leading Employer Promoting Healthy Lifestyles for Its Employees 3
EZ-PSA is a one-step immunoassay for the rapid, qualitative determination of human Prostate Specific Antigen (PSA) in whole blood. The test is intended for professional use as an aid in the diagnosis...
Rapid Tumor Marker Test: Prostate Specific Antigen...
Remote Control Vision Tester Can Administer Basic,Distance Vision Tests in Less Than 2 Minutes....
... Quality of Vision and Contrast Sensitivity. ... illumination and glare luminance levels for ... testing with/without glare and background luminance ... ANSI standards. All Light Levels Microprocessor ...
Medicine Products: